Zenatane

Drug Dr.Reddy's Laboratories,Inc.
Total Payments
$21,860
Transactions
34
Doctors
31
Companies
2

Payment Trends by Year

Year Amount Transactions Doctors
2023 $20,240 6 4
2018 $265.54 6 6
2017 $1,355 22 21

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $20,441 9 93.5%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,000 1 4.6%
Food and Beverage $388.35 23 1.8%
Travel and Lodging $30.42 1 0.1%

Top Doctors Receiving Payments for Zenatane — Page 2

Doctor Specialty Location Total Records
, DO Dermatology Fremont, CA $11.50 1
, MD Dermatology Stamford, CT $11.49 1
, MD Dermatology New York, NY $6.80 1
, MD Dermatology Dallas, TX $5.22 1
, D.O Dermatology Brooklyn, NY $5.07 1
, M.D., P.C Specialist Brooklyn, NY $3.91 1

About Zenatane

Zenatane is a drug associated with $21,860 in payments to 31 healthcare providers, recorded across 34 transactions in the CMS Open Payments database. The primary manufacturer is Dr.Reddy's Laboratories,Inc..

Payment data is available from 2017 to 2023. In 2023, $20,240 was paid across 6 transactions to 4 doctors.

The most common payment nature for Zenatane is "Consulting Fee" ($20,441, 93.5% of total).